Bausch Health Companies Inc.

Bausch Health Companies is a specialty pharmaceutical and medical device manufacturer headquartered in Laval, Quebec, with operations spanning multiple therapeutic areas and geographic markets. The company develops, manufactures, and markets products across gastroenterology, hepatology, neurology, dermatology, eye health, and aesthetic medicine, alongside a portfolio of generic pharmaceuticals and over-the-counter products. Its product range includes both branded specialty drugs and generic formulations distributed internationally.

The company operates through five business segments. Salix focuses on gastroenterology products, while Bausch + Lomb specializes in vision care, surgical products, and ophthalmic pharmaceuticals. Solta Medical handles aesthetic medical devices, the International segment sells aesthetic devices, branded and generic pharmaceuticals, and OTC products across markets outside North America, and the Diversified segment encompasses neurology and dermatology pharmaceuticals, generic drugs, and dentistry products. This structure reflects the company's acquisition and integration history, including its 2018 name change from Valeant Pharmaceuticals International.

With approximately 20,700 full-time employees, Bausch Health maintains a substantial manufacturing and distribution footprint to support its diverse product portfolio. The company serves both institutional and retail channels across North American and international markets, positioning it as a significant player in specialty pharmaceuticals and medical aesthetics despite operating across multiple therapeutic segments.